Delivery Order SPE2DE21D0017-SPE2D625F3DWD
- Not listed
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories, was awarded a $1,344.00 delivery order contract on August 14, 2025, by the Defense Logistics Agency's Medical Supply Chain for diagnostic testing supplies and equipment. The contract, designated as a fixed-price agreement with economic price adjustment, calls for delivery of ID NOW Strep A Qualification Detection Mobile Lab Test kits to Lockhart, Florida, with an ultimate completion date of August 19, 2025. This delivery...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a delivery order valued at $4,800.00 on August 20, 2025, for COVID-19 test kits under contract 4569160719. This fixed-price contract with economic price adjustment has an ultimate completion date of August 29, 2025, and will be performed in Lockhart, Florida. The award was issued by the Defense Logistics Agency Medical Supply Chain without a set-aside designation, indicating open competition among...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a $3,360 fixed-price delivery order with economic price adjustment on July 22, 2025, by the Defense Logistics Agency Medical Supply Chain. The contract, designated as a Kit ID NOW Strip A2 Qual Detect Mobile Test delivery order, is scheduled for ultimate completion on July 23, 2025, and will be performed in Lockhart, Florida. No set-aside designation was applied to this award, indicating full and open...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a $15,000 fixed-price delivery order with economic price adjustment for COVID-19 test kits on August 7, 2025, with an ultimate completion date of August 18, 2025. The contract, issued without set-aside designation, is funded by the Defense Logistics Agency Medical Supply Chain and specifies performance at the contractor's facility in Lockhart, Florida. This delivery order represents a continuation of...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a delivery order valued at $3,600.00 on September 9, 2025, for COVID-19 test kits under contract 4569386625. The contract utilizes fixed-price pricing with economic price adjustment and has an ultimate completion date of September 18, 2025. Performance will occur in Lockhart, Florida. The award was made without a set-aside designation, indicating open competition. The funding source is the Defense...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a delivery order valued at $3,360.00 for ID NOW Strip A2 Qual Detect Microlab Test kits on August 22, 2025. The contract utilizes a fixed-price structure with economic price adjustment provisions and does not include a set-aside designation, indicating competition was conducted on an unrestricted basis. Performance will be completed in Lockhart, Florida, with an ultimate completion date of August 26, 2025....
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., has been awarded a delivery order valued at $1,407.07 for BinaxNOW COVID-19 antigen test cards. This fixed-price contract with economic price adjustment was awarded on July 25, 2025, with an ultimate completion date of August 15, 2025, and will be performed in Lockhart, Florida. The award was issued without a set-aside designation, indicating open competition. Funding is provided through the Defense Logistics Agency...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a delivery order on August 18, 2025, for BinaxNOW COVID-19 antigen test cards with a ceiling value of $1,206.06. This fixed-price contract with economic price adjustment was funded by the Defense Logistics Agency Medical Supply Chain and will be performed in Lockhart, Florida. The contract represents an open competition award with no set-aside designation and is scheduled for ultimate completion on September...
- This federal contract award to Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories, is for the delivery of BinaxNOW COVID-19 antigen test kits and related materials to the Defense Logistics Agency (DLA) Troop Support Medical and various Veterans Health Administration (VHA) networks. The award, valued at $1,407.07, is a delivery order under a larger indefinite delivery vehicle (IDV) and has a completion date of September 30, 2024. The contract is a fixed-price with economic...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., received a delivery order award valued at $4,422.22 on July 30, 2025, for BinaxNOW COVID-19 antigen cards to be delivered to Lockhart, Florida. The contract employs a fixed-price structure with economic price adjustment provisions and carries an ultimate completion date of August 20, 2025. The award was made without a set-aside designation, indicating open competition among qualified vendors. The Defense Logistics...
- SPE2DE21D0017Indefinite Delivery Contract
- SPE2DE21D0017-SPE2D625F3DWDDelivery Order
Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories specializing in medical diagnostics, was awarded a $6,000 fixed-price delivery order for ID NOW COVID-19 virus test kits by the Defense Logistics Agency Medical Supply Chain on September 11, 2025. The delivery order, which has no set-aside designation, indicates open competition and carries an ultimate completion date of September 19, 2025. The performance location is identified as Lockhart, Florida. This award represents a continuation of Abbott Rapid DX North America LLC's established role as a critical supplier of COVID-19 diagnostic products to federal healthcare agencies, particularly the Department of Defense and Department of Veterans Affairs. This delivery order is part of the contractor's broader portfolio of fixed-price contracts with economic price adjustment mechanisms that have consistently supported federal testing and diagnostic needs. Abbott Rapid DX North America LLC maintains multiple Indefinite Delivery Vehicles with various Veterans Integrated Service Networks, including significant blanket purchase agreements for BinaxNOW COVID-19 antigen test kits and other point-of-care diagnostic equipment. The contractor's sustained engagement with the DLA Medical Supply Chain and VA reflects the ongoing federal requirement for reliable diagnostic testing capabilities across military and veteran healthcare facilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.0k | 9/11/25 |